Company Overview of PeriCor Therapeutics, Inc.
PeriCor Therapeutics, Inc., a specialty biopharmaceutical company, develops and commercializes novel therapies to protect threatened heart muscle in surgical and acute settings. It develops adenosine regulating agents, which amplifies the body’s own protective response to ischemia, and reperfusion injury and tissue damage that occurs after interrupted blood flow is restored. PeriCor Therapeutics, Inc. was incorporated in 2004 and is based in New York, New York.
350 Fifth Avenue
New York, NY 10118
Founded in 2004
Key Executives for PeriCor Therapeutics, Inc.
Similar Private Companies By Industry
|Nutrition53, Inc.||United States|
|Variant Pharmaceuticals, Inc.||United States|
|Good To Grow LLC||United States|
|R-Pharm-US LLC||United States|
|JoMo Nutrition USA, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact PeriCor Therapeutics, Inc., please visit www.pericortherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.